Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lenvima
Pharma
BMS, China reimbursement update, CAR-T hold—Fierce Pharma Asia
BMS signed a massive ADC deal. AZ and Gilead's ADCs passed on China's national insurance scheme. The FDA put three CARsgen CAR-Ts on clinical hold.
Angus Liu
Dec 15, 2023 5:15am
Merck, Eisai combo flops again, this time in endometrial cancer
Dec 8, 2023 12:27pm
AZ-Daiichi, Padcev, AbbVie—Fierce Pharma Asia
Sep 29, 2023 10:45am
Merck and Eisai's cancer combo flops 2 more trials
Sep 22, 2023 9:51am
Vyvanse, Keytruda-Lenvima, Adagene-ADC—Fierce Pharma Asia
Sep 1, 2023 8:50am
Another Keytruda-Lenvima hope shattered at Merck, Eisai
Aug 25, 2023 10:35am